Nureca Limited (NURECA) - Net Assets
Based on the latest financial reports, Nureca Limited (NURECA) has net assets worth Rs1.99 Billion INR (≈ $21.49 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs2.25 Billion ≈ $24.30 Million USD) and total liabilities (Rs259.46 Million ≈ $2.81 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NURECA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs1.99 Billion |
| % of Total Assets | 88.45% |
| Annual Growth Rate | 242.57% |
| 5-Year Change | 19.12% |
| 10-Year Change | N/A |
| Growth Volatility | 5458.92 |
Nureca Limited - Net Assets Trend (2017–2025)
This chart illustrates how Nureca Limited's net assets have evolved over time, based on quarterly financial data. Also explore NURECA total asset value for the complete picture of this company's asset base.
Annual Net Assets for Nureca Limited (2017–2025)
The table below shows the annual net assets of Nureca Limited from 2017 to 2025. For live valuation and market cap data, see NURECA company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs1.94 Billion ≈ $21.01 Million |
+0.61% |
| 2024-03-31 | Rs1.93 Billion ≈ $20.88 Million |
-0.91% |
| 2023-03-31 | Rs1.95 Billion ≈ $21.08 Million |
-4.09% |
| 2022-03-31 | Rs2.03 Billion ≈ $21.98 Million |
+24.59% |
| 2021-03-31 | Rs1.63 Billion ≈ $17.64 Million |
+992.13% |
| 2020-03-31 | Rs149.34 Million ≈ $1.62 Million |
+74.77% |
| 2019-03-31 | Rs85.45 Million ≈ $924.11K |
+396.80% |
| 2018-03-31 | Rs17.20 Million ≈ $186.01K |
+16689.33% |
| 2017-03-31 | Rs102.45K ≈ $1.11K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Nureca Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 35494585.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs868.20 Million | 44.69% |
| Common Stock | Rs100.00 Million | 5.15% |
| Other Comprehensive Income | Rs-13.15 Million | -0.68% |
| Other Components | Rs987.80 Million | 50.84% |
| Total Equity | Rs1.94 Billion | 100.00% |
Nureca Limited Competitors by Market Cap
The table below lists competitors of Nureca Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BMG Resources Ltd
AU:BMG
|
$27.51 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
$27.52 Million |
|
Bowen Acquisition Corp Ordinary Shares
NASDAQ:BOWN
|
$27.52 Million |
|
Global Vectra Helicorp Limited
NSE:GLOBALVECT
|
$27.52 Million |
|
Qmines Ltd
AU:QML
|
$27.49 Million |
|
Earlypay Ltd
AU:EPY
|
$27.49 Million |
|
Volitionrx Ltd
NYSE MKT:VNRX
|
$27.48 Million |
|
GWR Group Ltd
AU:GWR
|
$27.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nureca Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,931,110,000 to 1,942,850,000, a change of 11,740,000 (0.6%).
- Net income of 8,460,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 80,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs8.46 Million | +0.44% |
| Other Comprehensive Income | Rs-80.00K | -0.0% |
| Other Changes | Rs3.36 Million | +0.17% |
| Total Change | Rs- | 0.61% |
Book Value vs Market Value Analysis
This analysis compares Nureca Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.37x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7433.43x to 1.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | Rs0.04 | Rs266.51 | x |
| 2018-03-31 | Rs2.41 | Rs266.51 | x |
| 2019-03-31 | Rs11.98 | Rs266.51 | x |
| 2020-03-31 | Rs21.33 | Rs266.51 | x |
| 2021-03-31 | Rs218.18 | Rs266.51 | x |
| 2022-03-31 | Rs203.19 | Rs266.51 | x |
| 2023-03-31 | Rs194.88 | Rs266.51 | x |
| 2024-03-31 | Rs193.11 | Rs266.51 | x |
| 2025-03-31 | Rs194.22 | Rs266.51 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nureca Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.44%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.77%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.08x
- Recent ROE (0.44%) is below the historical average (38.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 2.39% | 1.24% | 0.24x | 8.08x | Rs-7.80K |
| 2018 | 180.93% | 15.52% | 2.86x | 4.08x | Rs29.40 Million |
| 2019 | 72.86% | 10.06% | 2.63x | 2.75x | Rs53.72 Million |
| 2020 | 42.82% | 6.43% | 2.93x | 2.27x | Rs49.02 Million |
| 2021 | 28.43% | 21.73% | 1.15x | 1.14x | Rs300.64 Million |
| 2022 | 22.13% | 17.59% | 1.17x | 1.08x | Rs246.40 Million |
| 2023 | -4.23% | -7.41% | 0.54x | 1.06x | Rs-277.38 Million |
| 2024 | -0.93% | -1.95% | 0.45x | 1.06x | Rs-211.05 Million |
| 2025 | 0.44% | 0.77% | 0.52x | 1.08x | Rs-185.82 Million |
Industry Comparison
This section compares Nureca Limited's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $86,000
- Average return on equity (ROE) among peers: -32.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nureca Limited (NURECA) | Rs1.99 Billion | 2.39% | 0.13x | $27.50 Million |
| Universus Photo Imagings Limited (UNIVPHOTO) | $86.00K | -32.56% | 0.13x | $58.07 Million |
About Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more